Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-04 10:35 am Purchase | 13G | Sera Prognostics, Inc. SERA | Domain Partners VIII L.P. | 2,523,771 8.6% | 2,523,771 (New Position) | View |
| 2021-01-21 5:48 pm Sale | 13G | aTyr Pharma, Inc. LIFE | Domain Partners VIII L.P. | 89,425 0.9% | -1,718,395 (-95.05%) | View |
| 2021-01-20 7:57 pm Sale | 13G | Syndax Pharmaceuticals, Inc. SNDX | Domain Partners VIII L.P. | 1,162,554 2.5% | -581,300 (-33.33%) | View |
| 2021-01-20 6:33 pm Sale | 13G | Milestone Pharmaceuticals Inc. MIST | Domain Partners VIII L.P. | 860,724 2.9% | -1,012,381 (-54.05%) | View |
| 2021-01-20 5:54 pm Sale | 13G | Bionano Genomics, Inc. BNGO | Domain Partners VIII L.P. | 0 0% | -958,878 (Position Closed) | View |
| 2020-01-10 4:04 pm Sale | 13G | Veracyte, Inc. VCYT | Domain Partners VIII L.P. | 0 0% | -2,266,994 (Position Closed) | View |
| 2020-01-09 5:18 pm Purchase | 13G | Milestone Pharmaceuticals Inc. MIST | Domain Partners VIII L.P. | 1,873,105 7.6% | 1,873,105 (New Position) | View |
| 2019-05-13 4:46 pm Purchase | 13D | Adynxx, Inc. ADYX | Domain Partners VIII L.P. | 3,036,044 52.3% | 3,036,044 (New Position) | View |
| 2019-01-11 10:59 am Purchase | 13G | Bionano Genomics, Inc. BNGO | Domain Partners VIII L.P. | 958,878 9.5% | 958,878 (New Position) | View |
| 2019-01-11 10:53 am Sale | 13G | Veracyte, Inc. VCYT | Domain Partners VIII L.P. | 2,266,994 5.6% | -496,300 (-17.96%) | View |
| 2018-11-05 10:30 am Sale | 13D | Dicerna Pharmaceuticals, Inc. DRNA | Domain Partners VIII L.P. | 2,919,056 4.7% | -571,014 (-16.36%) | View |